Gladstone NOW: The Campaign Join Us on the Journey ✕
451 - 465 of 1448 Results Clear All
Hannah Watry shares her love of tap dancing and why she decided to launch RA Appreciation Week at Gladstone
Research Associates Committee Profile Conklin Lab
ABC News—COVID-19 case numbers are rising in the San Francisco Bay Area, driven by sublineages of the Omicron variant. Gladstone virologist Warner Greene explains that the new subvariants are more infectious, and can evade the antibodies produced in response to vaccination and previous infection.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
STAT News—COVID-19 case numbers are rising once again across the United States. Melanie Ott, director of the Gladstone Institute of Virology, explains that the virus is adapting to a new immune landscape, with variants emerging that are able to cause infection even in individuals who were previously infected.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
New class of resistance-proof drugs could one day transform treatments for viral diseases
News Release Research (Publication) Center for Cell Circuitry Infectious Disease Weinberger Lab Chaturvedi
Gladstone auctions off a painting to create a new fund that will support postdoctoral scholars
History Institutional News
Here’s what five mothers in STEM have to say about how organizations can better support them
Diversity Profile Womens Initiative
Gladstone scientists show that reducing levels of the protein tau soon after birth can prevent these conditions in an experimental model
News Release Research (Publication) Epilepsy Neurological Disease Mucke Lab
KCBS News—Although Omicron and related new variants can infect vaccinated people, Senior Investigator Warner Greene says vaccines still protect us well against severe disease, and urges people to get at least one booster shot.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
San Francisco Chronicle—Two decades ago, Gladstone commissioned a landscape painting from the artist Wayne Thiebaud. Now the painting is up for auction, with the proceeds targeted to supporting scientific training at Gladstone in honor of the painter’s legacy of mentorship.
Institutional News
Scientists from Gladstone and UC San Francisco systematically tested ways to improve the efficacy of therapeutic cells targeting cancer
News Release Research (Publication) Cancer Genomic Immunology
Fierce Biotech—Alexander Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues at UC San Francisco and the Salk Institute for Biological Studies, recently showed that obese mice with atopic dermatitis had an altered immune response that made them refractory to anti-inflammatory treatment. Fierce Biotech discusses the implications of this finding for the development of drugs against inflammation and asthma.
Gladstone Experts Genomic Immunology Marson Lab Disease Models
A new platform designed by Gladstone scientists for studying how the immune system responds to hepatitis C virus could speed the hunt for a vaccine
News Release Research (Publication) Hepatitis C Infectious Disease McDevitt Lab Ott Lab Organoids
Catherine Tcheandjieu joins Gladstone Institutes to uncover what predisposes people from diverse ancestries to disease
Institutional News News Release Profile Cardiovascular Disease Data Science and Biotechnology Tcheandjieu Lab
A new catalog to help better understand how HIV hijacks human cells
Research (Publication) HIV/AIDS Data Science and Biotechnology Genomic Immunology Infectious Disease Krogan Lab Marson Lab
ABC News—The FDA recently announced that they would authorize a second COVID-19 vaccine booster shot for people 50 and older, and those 12 and older who are immunocompromised. Senior Investigator Warner Greene explains that the second booster can protect people who don’t have vigorous immune systems from infection, and predicts that it may be more broadly recommended for all adults in the months to come.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
